Nektar Therapeutics (NASDAQ:NKTR) has an interesting drug in its pipeline, rezpegaldesleukin (rezpeg), that has the potential to treat inflammation in a new way. The...
By Mircely Guanipa, Deisy Buitrago and Marianna Parraga PUNTO FIJO/CARACAS/HOUSTON (Reuters) – Iran and Venezuela are trying to patch together an oil alliance that...
SELLAS Life Sciences Group Inc. (NASDAQ: NASDAQ:) today announced it has successfully regained compliance with the Nasdaq Listing Rule 5550(b)(2), concerning the minimum market...
Investing.com — Oil prices settled lower on Tuesday, as investors weighed up a hotter-than-expected U.S inflation report and a still-upbeat OPEC outlook on crude...